Paper36986830
Pharmacologic Management of Monogenic and Very Early Onset Inflammatory Bowel Diseases.
Levine AE and 4 others. Pharmaceutics, 2023. Cited by 16 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pharmacologic Management of Monogenic and Very Early Onset Inflammatory Bowel Diseases. Papers, record 36986830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36986830
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References144
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19967552 | Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency. | J Clin Immunol | 2010 | https://conductscience.org/library/papers/19967552 | PubMed |
| 2 | 13679528 | Growth hormone insensitivity associated with a STAT5b mutation. | N Engl J Med | 2003 | https://conductscience.org/library/papers/13679528 | PubMed |
| 3 | 31126015 | A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31126015 | PubMed |
| 4 | 23060872 | Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. | Front Immunol | 2012 | https://conductscience.org/library/papers/23060872 | PubMed |
| 5 | 17324398 | Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. | Gastroenterology | 2007 | https://conductscience.org/library/papers/17324398 | PubMed |
| 6 | 26783323 | A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. | J Exp Med | 2016 | https://conductscience.org/library/papers/26783323 | PubMed |
| 7 | 31885858 | Recent advances in understanding and managing pediatric inflammatory bowel disease. | F1000Res | 2019 | https://conductscience.org/library/papers/31885858 | PubMed |
| 8 | 21209123 | Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. | Gut | 2011 | https://conductscience.org/library/papers/21209123 | PubMed |
| 9 | 33026087 | The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update. | J Crohns Colitis | 2021 | https://conductscience.org/library/papers/33026087 | PubMed |
| 10 | 30622297 | Selective Janus kinase inhibitors come of age. | Nat Rev Rheumatol | 2019 | https://conductscience.org/library/papers/30622297 | PubMed |
| 11 | 9850454 | Benefits of pre-emptive dose reduction for Sandimmune to Neoral conversion in stable renal transplant recipients. | Clin Transplant | 1998 | https://conductscience.org/library/papers/9850454 | PubMed |
| 12 | 24531849 | Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature. | Clin Rheumatol | 2014 | https://conductscience.org/library/papers/24531849 | PubMed |
| 13 | 18845326 | Omenn syndrome is associated with mutations in DNA ligase IV. | J Allergy Clin Immunol | 2008 | https://conductscience.org/library/papers/18845326 | PubMed |
| 14 | 31232887 | Risk-factors Associated With Poor Outcomes in VEO-IBD Secondary to XIAP Deficiency: A Case Report and Literature Review. | J Pediatr Gastroenterol Nutr | 2019 | https://conductscience.org/library/papers/31232887 | PubMed |
| 15 | 8944573 | Leucocyte adhesion deficiency presenting as a chronic ileocolitis. | Gut | 1996 | https://conductscience.org/library/papers/8944573 | PubMed |
| 16 | 25419596 | Infliximab therapy in pediatric patients 7 years of age and younger. | J Pediatr Gastroenterol Nutr | 2014 | https://conductscience.org/library/papers/25419596 | PubMed |
| 17 | 21337668 | Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center. | Inflamm Bowel Dis | 2011 | https://conductscience.org/library/papers/21337668 | PubMed |
| 18 | 29409871 | Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease. | Gastroenterology | 2018 | https://conductscience.org/library/papers/29409871 | PubMed |
| 19 | 10896064 | Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. | J Pediatr Gastroenterol Nutr | 2000 | https://conductscience.org/library/papers/10896064 | PubMed |
| 20 | 32047622 | Precision medicine in inflammatory bowel disease: concept, progress and challenges. | F1000Res | 2020 | https://conductscience.org/library/papers/32047622 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42118445 | Lactiplantibacillus plantarum AS21 Reduces Colitis in Mice by Modulating Inflammation, Gut Barrier Function, and Microbiota in an Intervention Dose and Time-dependent Manner. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/42118445 | PubMed |
| 41981702 | Cross-talk of gut-bone-muscle: osteosarcopenia in experimental colitis models. | Lab Anim Res | 2026 | https://conductscience.org/library/papers/41981702 | PubMed |
| 41901662 | Cutaneous Manifestations of Inborn Errors of Immunity: Clinical Clues to Immune Disorders. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/41901662 | PubMed |
| 41840589 | Clinical features and prognostic analysis of very early-onset inflammatory bowel disease. | BMC Pediatr | 2026 | https://conductscience.org/library/papers/41840589 | PubMed |
| 41714924 | Monogenic forms of inflammatory bowel disease: Genetic mechanisms, models, and clinical implications. | Mol Med | 2026 | https://conductscience.org/library/papers/41714924 | PubMed |
| 41540376 | Targeted therapies and their outcomes in monogenic very early onset inflammatory bowel disease: a systematic review. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/41540376 | PubMed |
| 41426201 | Adalimumab-responsive Monogenic Inflammatory Bowel Disease With Pseudopolyposis Characteristic of TGFBR2 Variant in Loeys-Dietz Syndrome. | DEN Open | 2026 | https://conductscience.org/library/papers/41426201 | PubMed |
| 40721512 | The impact of genetic immune disorders on infections including COVID-19, inflammatory bowel disease and cancer. | Nat Immunol | 2025 | https://conductscience.org/library/papers/40721512 | PubMed |
| 40672687 | Azathioprine Metabolites in Erythrocytes and DNA for Therapy Monitoring in Very Early Onset Inflammatory Bowel Disease Pediatric Patients. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40672687 | PubMed |
| 40426715 | Genetic Variants in Early-Onset Inflammatory Bowel Disease: Monogenic Causes and Clinical Implications. | Children (Basel) | 2025 | https://conductscience.org/library/papers/40426715 | PubMed |
| 40310351 | Paediatric Congenital Enteropathies: Clinical and Histological Review. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40310351 | PubMed |
| 39857906 | Dual Biologic or Small Molecule Therapy in Pediatric Inflammatory Bowel Disease: A Single Center Experience. | Children (Basel) | 2025 | https://conductscience.org/library/papers/39857906 | PubMed |
| 37447355 | Anti-Inflammatory Effect and Signaling Mechanism of Glycine max Hydrolyzed with Enzymes from Bacillus velezensis KMU01 in a Dextran-Sulfate-Sodium-Induced Colitis Mouse Model. | Nutrients | 2023 | https://conductscience.org/library/papers/37447355 | PubMed |
Genes46
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36986830
GET https://conductscience.org/api/papers/v1/36986830/references?page=2